Stock Price
13.42
Daily Change
-0.02 -0.15%
Monthly
-5.63%
Yearly
76.35%
Q2 Forecast
13.04

Viatris reported $0.57 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.52 0.50 May/11
FY2025Q4 Dec/2025 0.57 0.53 0.54 Feb/26
FY2025Q3 Sep/2025 0.67 0.62 0.75 Nov/06
FY2025Q2 Jun/2025 0.62 0.55 0.69 Aug/07
FY2025Q1 Mar/2025 0.50 0.53 0.67 May/08




Eps Change Date
Celltrion KRW 1.55K 735.24 Mar/2026
Cspc Pharmaceutical CNY 0 0.08 Dec/2025
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Divis Laboratories Ltd INR 21.98 3.99 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.09 0.12 Dec/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.16 0.02 Dec/2025
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pharma Mar EUR 3.34 3.57 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Sartorius EUR 1.26 0.63 Dec/2025
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Zealand Pharma A/S -8.34 2.6 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025